• Something wrong with this record ?

Fibrilace síní a městnavé srdeční selhání
[Atrial fibrillation and congestive heart failure]

Denis Roy, Mario Talajic, Marc Dubuc, Bernard Thibault, Peter Guerra, Laurent Macle, Paul Khairy

. 2009 ; 3 (1) : 2-7.

Language Czech Country Czech Republic

Persistent link   https://www.medvik.cz/link/bmc07526103

The present review will examine the prognostic importance of atrial fibrillation and heart failure, explore the different therapeutic options for treating atrial fibrillation and present the results of the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. RECENT FINDINGS: The Atrial Fibrillation and Congestive Heart Failure trial was a randomized trial involving patients with both atrial fibrillation and heart failure. The trial was designed to compare the maintenance of sinus rhythm with the control of ventricular rate in patients with left ventricular dysfunction, heart failure and a history of atrial fibrillation. There was no significant difference in the rate of death from cardiovascular causes in the rhythm-control group as compared with the rate-control strategy. In addition, there was no significant difference in any of the secondary outcomes including death from any cause, worsening heart failure or stroke. The rate-control strategy eliminated the need for repeated cardioversion and reduced rates of hospitalization. SUMMARY: The results of the Atrial Fibrillation and Congestive Heart Failure trial indicate that a routine strategy of rhythm control does not reduce rate of death and suggest that rate control should be considered a primary approach for patients with atrial fibrillation and heart failure.

Atrial fibrillation and congestive heart failure

Bibliography, etc.

Lit.: 70

000      
00000naa 2200000 a 4500
001      
bmc07526103
003      
CZ-PrNML
005      
20181214102151.0
008      
090708s2009 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Roy, Denis
245    10
$a Fibrilace síní a městnavé srdeční selhání / $c Denis Roy, Mario Talajic, Marc Dubuc, Bernard Thibault, Peter Guerra, Laurent Macle, Paul Khairy
246    11
$a Atrial fibrillation and congestive heart failure
314    __
$a Montreal Heart Institute and Department of Medicine, Université de Montréal, Montreal, Quebec, Canada denis.roy@umontreal.ca
504    __
$a Lit.: 70
520    9_
$a The present review will examine the prognostic importance of atrial fibrillation and heart failure, explore the different therapeutic options for treating atrial fibrillation and present the results of the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. RECENT FINDINGS: The Atrial Fibrillation and Congestive Heart Failure trial was a randomized trial involving patients with both atrial fibrillation and heart failure. The trial was designed to compare the maintenance of sinus rhythm with the control of ventricular rate in patients with left ventricular dysfunction, heart failure and a history of atrial fibrillation. There was no significant difference in the rate of death from cardiovascular causes in the rhythm-control group as compared with the rate-control strategy. In addition, there was no significant difference in any of the secondary outcomes including death from any cause, worsening heart failure or stroke. The rate-control strategy eliminated the need for repeated cardioversion and reduced rates of hospitalization. SUMMARY: The results of the Atrial Fibrillation and Congestive Heart Failure trial indicate that a routine strategy of rhythm control does not reduce rate of death and suggest that rate control should be considered a primary approach for patients with atrial fibrillation and heart failure.
650    _2
$a beta blokátory $x terapeutické užití $7 D000319
650    _2
$a antiarytmika $x terapeutické užití $7 D000889
650    _2
$a antikoagulancia $x terapeutické užití $7 D000925
650    _2
$a fibrilace síní $x epidemiologie $x farmakoterapie $x komplikace $7 D001281
650    _2
$a kardiomyopatie $x diagnóza $x etiologie $7 D009202
650    _2
$a katetrizační ablace $7 D017115
650    _2
$a komorbidita $7 D015897
650    _2
$a digoxin $x terapeutické užití $7 D004077
650    _2
$a srdeční selhání $x epidemiologie $x komplikace $7 D006333
650    _2
$a srdeční frekvence $7 D006339
650    _2
$a lidé $7 D006801
650    _2
$a randomizované kontrolované studie jako téma $7 D016032
650    _2
$a tachykardie $x komplikace $7 D013610
700    1_
$a Talajic, Mario
700    1_
$a Dubuc, Marc
700    1_
$a Thibault, Bernard
700    1_
$a Guerra, Peter
700    1_
$a Macle, Laurent $7 xx0230440
700    1_
$a Khairy, Paul
773    0_
$w MED00156016 $t Current opinion in cardiology $g Roč. 3, č. 1 (2009), s. 2-7 $x 1802-3711
910    __
$a ABA008 $b B 2480 $c 414 $y 9 $z 0
990    __
$a 20090708154447 $b ABA008
991    __
$a 20181214102318 $b ABA008
999    __
$a ok $b bmc $g 666357 $s 523410
BAS    __
$a 3
BMC    __
$a 2009 $b 3 $c 1 $d 2-7 $i 1802-3711 $m Current opinion in cardiology (České vyd.) $x MED00156016
LZP    __
$a 2009-22/mkme

Find record

Citation metrics

Logged in users only

Archiving options